sHEMs were designed to be specific to each TCS, allowing one to discriminate between TCSs in heterogeneous FFPE tumor samples rather than relying on commonly used non-specific markers (e.g., PD-1 as a marker for exhaustion). This evidence concerns the gene PDCD1 and neoplasm.